COMMUNIQUÉS West-GlobeNewswire

Devenez membre PREMIUM

Accèdez sans limite aux 15 000 actualités du site
et recevez gratuitement chaque semaine,
la Newsletter Santé log avec les actus Santé à ne pas manquer !

S'abonner
29€ TTC/an

Je suis déjà membre PREMIUM

Se connecter

Respilean Review (BREAKING NEWS): Why Thousands Are Calling It the Natural Lung Breakthrough of 2025
01/04/2025 - 22:30
DENVER, April 01, 2025 (GLOBE NEWSWIRE) -- In a world where we measure everything—from step counts to calories—there’s one thing we rarely track until it’s already compromised: our lung health . With pollution rising, [...]
HCW Biologics Announces 1-for-40 Reverse Stock Split
01/04/2025 - 22:35
MIRAMAR, Fla., April 01, 2025 (GLOBE NEWSWIRE) -- HCW Biologics Inc. (the “Company” or “HCW Biologics”) (NASDAQ: HCWB), a clinical-stage biopharmaceutical company focused on discovering and developing novel [...]
Venus Concept Announces $11 million Debt-to-Equity Exchange Transaction
01/04/2025 - 22:45
Continued improvement of the Company’s financial position through additional reduction of outstanding debt by Madryn Asset Management TORONTO, April 01, 2025 (GLOBE NEWSWIRE) -- Venus Concept Inc. (“Venus Concept” or [...]
BioStem Technologies Announces Extension to File 2024 Annual Report with OTC
01/04/2025 - 22:49
POMPANO BEACH, Fla., April 01, 2025 (GLOBE NEWSWIRE) -- BioStem Technologies, Inc. (OTC: BSEM), a leading MedTech company specializing in the development, manufacturing, and commercialization of placental-derived [...]
Pennant Expands Portfolio with Acquisition of Senior Living Community in Arizona
01/04/2025 - 22:53
EAGLE, Idaho, April 01, 2025 (GLOBE NEWSWIRE) -- The Pennant Group, Inc. (NASDAQ: PNTG), the parent company of the Pennant group of affiliated home health, hospice, home care and senior living companies, announces the [...]
Cidara Therapeutics Reports Inducement Grant Under Nasdaq Listing Rule 5635(C)(4)
01/04/2025 - 22:56
SAN DIEGO, April 01, 2025 (GLOBE NEWSWIRE) -- Cidara Therapeutics, Inc. (Nasdaq: CDTX), a biotechnology company using its proprietary Cloudbreak ®  platform to develop drug-Fc conjugate (DFC) immunotherapies, today [...]
Inventiva annonce la fin du recrutement de l’étude clinique de Phase 3 NATiV3 évaluant lanifibranor chez les patients atteints de MASH et de fibrose avancée
01/04/2025 - 23:00
Objectifs de recrutement dépassés avec 1.009 patients randomisés dans la cohorte principale et 411 dans la cohorte exploratoire Principaux résultats de NATiV3 attendus au deuxième semestre 2026 et, si positifs, ils [...]
Inventiva announces completion of enrollment in the Phase 3 NATiV3 clinical trial of lanifibranor in patients with MASH and advanced fibrosis
01/04/2025 - 23:00
Target enrollment exceeded with 1009 patients randomized in the main cohort and 410 patients in the exploratory cohort Topline results from NATiV3 projected in the second half of 2026 and, if positive, expected to be [...]
Mise à disposition du Document d’Enregistrement Universel 2024, contenant le Rapport Financier Annuel
01/04/2025 - 17:39
Communiqué de presse Paris - Le 1 er avril 2025 - EUROAPI annonce la publication de son Document d’Enregistrement Universel 2024, au format ESEF, déposé auprès de l’Autorité des marchés financiers (AMF) le 1 er avril [...]
Availability of the 2024 Universal Registration Document, including the Annual Financial Report
01/04/2025 - 17:39
Press Release Paris – April 1, 2025 – EUROAPI announces the publication of its 2024 Universal Registration Document in ESEF format, filed with the French Autorité des marchés financiers (AMF) on April 1, 2025. The 2024 [...]
ProDentim Reviews (DOCTOR INVESTIGATES): The Probiotic Dental Hack Dentists Can’t Ignore in 2025
01/04/2025 - 17:42
Real users uncover what’s working—and what’s not—inside this trending oral probiotic now sweeping through the dental health market. ORLANDO, FL, April 01, 2025 (GLOBE NEWSWIRE) -- PRODENTIM In the fast-growing realm of [...]
Valneva : le vaccin contre le chikungunya, IXCHIQ®, désormais autorisé chez les adolescents dans l'UE
01/04/2025 - 17:45
Avec cet élargissement d’indication, IXCHIQ ® , le premier vaccin autorisé au monde contre le virus du chikungunya (CHIKV), est désormais disponible pour une administration dans l'Union Européenne (UE) chez les [...]
Valneva’s Chikungunya Vaccine IXCHIQ® Now Authorized in EU for Adolescents Aged 12 and Above
01/04/2025 - 17:45
With this extension, IXCHIQ ® , the first vaccine against the chikungunya virus (CHIKV), is now available for administration for individuals 12 years of age and older in the European Union (EU). Saint Herblain (France [...]
ProDentim Reviews (DOCTOR WARNING): Dentists & Buyers Reveal the Truth Behind This “Natural Smile Fix” Supplement
01/04/2025 - 18:12
2025 buyers reveal everything: From fresher breath and gum healing to the surprising downsides no one talks about. Ontario, April 01, 2025 (GLOBE NEWSWIRE) -- PRODENTIM In the fast-growing realm of oral health solutions [...]
Aptose Common Shares to Delist from Nasdaq as of April 2, 2025
01/04/2025 - 14:30
SAN DIEGO and TORONTO, April 01, 2025 (GLOBE NEWSWIRE) -- Aptose Biosciences Inc. (“Aptose” or the “Company”) (NASDAQ: APTO, TSX:APS), a clinical-stage precision oncology company developing a tuspetinib (TUS) based [...]
Clene to Present at the Jones Healthcare and Technology Innovation Conference
01/04/2025 - 14:30
SALT LAKE CITY, April 01, 2025 (GLOBE NEWSWIRE) -- Clene Inc. (Nasdaq: CLNN) (along with its subsidiaries, “Clene”) and its wholly owned subsidiary, Clene Nanomedicine Inc., a late clinical-stage biopharmaceutical [...]
Moleculin Doses First Patient in Pivotal, Adaptive Phase 3 MIRACLE Trial
01/04/2025 - 14:30
– Initial data readout on track for second half of 2025 HOUSTON, April 01, 2025 (GLOBE NEWSWIRE) -- Moleculin Biotech, Inc. , (Nasdaq: MBRX) (“Moleculin” or the “Company”), a late-stage pharmaceutical company with a [...]
REMINDER: Microbot Medical Announces Data from the Company’s ACCESS-PVI trial will be Presented via Podium Presentation at Society of Interventional Radiology Annual Meeting
01/04/2025 - 14:30
Company Reaffirms Expected Timing of FDA Decision With Respect to 510(K) Clearance of LIBERTY® During the Current Second Quarter BRAINTREE, Mass., April 01, 2025 (GLOBE NEWSWIRE) -- Microbot Medical Inc. (Nasdaq: MBOT [...]
Milestone Scientific Expands CompuFlo® Epidural System Footprint with InfiniSurg, LLC in New Jersey
01/04/2025 - 14:30
Dr. Roman Kosiborod, DO to Utilize CompuFlo® for Enhanced Precision in Pain Management Procedures ROSELAND, N.J., April 01, 2025 (GLOBE NEWSWIRE) -- Milestone Scientific Inc. (NYSE: MLSS) , a leading developer of [...]

Pages